Citadel Advisors’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-334
| Closed | -$2.25K | – | 7023 |
|
|
2023
Q4 | $2.25K | Buy |
+334
| New | +$2.25K | ﹤0.01% | 5670 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 6683 |
|
|
2023
Q1 | – | Sell |
-4,023
| Closed | -$142K | – | 6781 |
|
|
2022
Q4 | $142K | Buy |
4,023
+1,387
| +53% | +$49.1K | ﹤0.01% | 4857 |
|
|
2022
Q3 | $595K | Buy |
+2,636
| New | +$595K | ﹤0.01% | 3916 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 7159 |
|
|
2022
Q1 | – | Sell |
-3,970
| Closed | -$618K | – | 7333 |
|
|
2021
Q4 | $618K | Buy |
3,970
+1,951
| +97% | +$304K | ﹤0.01% | 4366 |
|
|
2021
Q3 | $405K | Buy |
+2,019
| New | +$405K | ﹤0.01% | 4741 |
|
|
2021
Q2 | – | Sell |
-29,665
| Closed | -$7.88M | – | 7278 |
|
|
2021
Q1 | $7.88M | Sell |
29,665
-1,978
| -6% | -$525K | ﹤0.01% | 1639 |
|
|
2020
Q4 | $11.7M | Buy |
31,643
+2,066
| +7% | +$762K | ﹤0.01% | 1168 |
|
|
2020
Q3 | $7.22M | Buy |
29,577
+134
| +0.5% | +$32.7K | ﹤0.01% | 1280 |
|
|
2020
Q2 | $8.48M | Buy |
29,443
+1,000
| +4% | +$288K | ﹤0.01% | 1186 |
|
|
2020
Q1 | $5.8M | Buy |
28,443
+13,931
| +96% | +$2.84M | ﹤0.01% | 1348 |
|
|
2019
Q4 | $6.49M | Buy |
14,512
+181
| +1% | +$80.9K | ﹤0.01% | 1453 |
|
|
2019
Q3 | $4.41M | Buy |
14,331
+4,370
| +44% | +$1.34M | ﹤0.01% | 1756 |
|
|
2019
Q2 | $3.17M | Buy |
+9,961
| New | +$3.17M | ﹤0.01% | 2029 |
|
|
2016
Q1 | – | Sell |
-168
| Closed | -$111K | – | 4088 |
|
|
2015
Q4 | $111K | Buy |
168
+98
| +140% | +$64.8K | ﹤0.01% | 3219 |
|
|
2015
Q3 | $33K | Sell |
70
-140
| -67% | -$66K | ﹤0.01% | 3628 |
|
|
2015
Q2 | $119K | Buy |
210
+193
| +1,135% | +$109K | ﹤0.01% | 3219 |
|
|
2015
Q1 | $141K | Buy |
+17
| New | +$141K | ﹤0.01% | 3188 |
|